Amarin Corp Plc (AMRN)

[Jt0082]

Ridiculous assertion. You are very wrong again.

Why wouldn't they:
1. They agreed to the MO placebo in the SPA - remember its THEIR CVOT study more so than Amarin's.
2. The RRR margin is so significant, its practically moot.
3. The FDA will hopefully see that you and others criticising placebo are merely doing it because you and your employer's business is threatened. Hopefully the FDA will ask some tough questions as they should, but will not allow conflicted people with biased agendas on the panel.